In-Vitro Toxicology Testing Market Report: Trends, Forecast and Competitive Analysis to 2030

In-Vitro Toxicology Testing Trends and Forecast

The future of the global in-vitro toxicology testing market looks promising with opportunities in the pharmaceutical industry, cosmetics & household product, academic institutes & research laboratories, diagnostic, chemicals industry, and food industry. The global in-vitro toxicology testing market is expected to reach an estimated $18.8 billion by 2030 with a CAGR of 9.3% from 2024 to 2030. The major drivers for this market are increasing attention to in vitro techniques for customized medicine and drug discovery, growing public opposition to animal experimentation, and work on early-stage toxicity detection through research and development.

A more than 150-page report is developed to help in your business decisions.

In-Vitro Toxicology Testing by Segment

The study includes a forecast for the global in-vitro toxicology testing by method, technology, application, end use, and region.

In-Vitro Toxicology Testing Market by Method [Shipment Analysis by Value from 2018 to 2030]:

• Cellular Assay
• Biochemical Assay
• In-Silico
• Ex-Vivo

In-Vitro Toxicology Testing Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Cell Culture Technology
• High Throughput Technology
• Molecular Imaging
• OMICS Technology

In-Vitro Toxicology Testing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Systemic Toxicology
• Dermal Toxicity
• Endocrine Disruption
• Occular Toxicity
• Others

In-Vitro Toxicology Testing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Pharmaceutical Industry
• Cosmetics & Household Products
• Academic Institutes & Research Laboratories
• Diagnostics
• Chemicals Industry
• Food Industry

In-Vitro Toxicology Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of In-Vitro Toxicology Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies in-vitro toxicology testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the in-vitro toxicology testing companies profiled in this report include-

• Charles River Laboratories International
• SGS
• Merck
• Eurofins Scientific
• Abbott Laboratories
• Laboratory Corporation of America
• Evotec
• Thermo Fisher Scientific
• Quest Diagnostics
• Agilent Technolgies

In-Vitro Toxicology Testing Market Insights

Lucintel forecasts that systemic toxicology will remain the largest segment over the forecast period.

North America will remain the largest region over the forecast period due to the rise in government funding for therapeutic research, the rise in healthcare spending, the development of sophisticated infrastructure and drug discovery procedures, and the robust regulatory environment for approval.

Features of the Global In-Vitro Toxicology Testing Market

Market Size Estimates: In-vitro toxicology testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: In-vitro toxicology testing market size by various segments, such as by method, technology, application, end use, and region in terms of value ($B).

Regional Analysis: In-vitro toxicology testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different method, technology, application, end use, and regions for the in-vitro toxicology testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the in-vitro toxicology testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the in-vitro toxicology testing market size?

Answer: The global in-vitro toxicology testing market is expected to reach an estimated $18.8 billion by 2030.

Q2. What is the growth forecast for in-vitro toxicology testing market?

Answer: The global in-vitro toxicology testing market is expected to grow with a CAGR of 9.3% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the in-vitro toxicology testing market?

Answer: The major drivers for this market are increasing attention to in vitro techniques for customized medicine and drug discovery, growing public opposition to animal experimentation, and work on early-stage toxicity detection through research and development.

Q4. What are the major segments for in-vitro toxicology testing market?

Answer: The future of the global in-vitro toxicology testing market looks promising with opportunities in the pharmaceutical industry, cosmetics & household product, academic institutes & research laboratories, diagnostic, chemicals industry, and food industry.

Q5. Who are the key in-vitro toxicology testing market companies?

Answer: The major drivers for this market are increasing attention to in vitro techniques for customized medicine and drug discovery, growing public opposition to animal experimentation, and work on early-stage toxicity detection through research and development.

• Charles River Laboratories International
• SGS
• Merck
• Eurofins Scientific
• Abbott Laboratories
• Laboratory Corporation of America
• Evotec
• Thermo Fisher Scientific
• Quest Diagnostics
• Agilent Technolgies

Q6. Which in-vitro toxicology testing market segment will be the largest in future?

Answer: Lucintel forecasts that systemic toxicology will remain the largest segment over the forecast period.

Q7. In in-vitro toxicology testing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to the rise in government funding for therapeutic research, the rise in healthcare spending, the development of sophisticated infrastructure and drug discovery procedures, and the robust regulatory environment for approval.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the in-vitro toxicology testing market by method (cellular assay, biochemical assay, in-silico, and ex-vivo), technology (cell culture technology, high throughput technology, molecular imaging, and omics technology), application (systemic toxicology, dermal toxicity, endocrine disruption, occular toxicity, and others), end use (pharmaceutical industry, cosmetics & household products, academic institutes & research laboratories, diagnostics, chemicals industry, and food industry), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?